AML

(redirected from acute myelogenous leukemia)
Also found in: Dictionary, Thesaurus, Medical, Financial, Encyclopedia.
AcronymDefinition
AMLAnti-Money Laundering
AMLAcute Myeloid Leukemia
AMLAcute Myelogenous Leukemia
AMLAbandoned Mine Land
AMLAcute Monocytic Leukemia (also seen as AMOL)
AMLAcute Myeloblastic Leukemia
AMLAzure Machine Learning (Microsoft)
AMLAnne-Marie Losique (Canadian television personality)
AMLAgent Modeling Language (computing)
AMLAcute Myelocytic Leukemia
AMLActon Main Line (UK; railway station)
AMLAbstract Machine Language
AMLAsn1 Markup Language
AMLAdvanced Media Library
AMLAutomated Mixed Media Library
AMLAston Martin Lagonda
AMLAdaptive Multi Line
AMLAcronym Master List
AMLAdded Main Line
AMLAppropriate Management Level (free-roaming animals)
AMLAdditional Maternity Leave (UK)
AMLAngiomyolipoma
AMLAll My Love
AMLApplication Markup Language (programming)
AMLAthletic Mic League (band)
AMLAgriculture and Markets Law (New York)
AMLAmerican Microsystems Ltd
AMLARC Macro Language
AMLAdvanced Measurement Laboratory (National Institute of Standards and Technology)
AMLAir Malawi (ICAO code)
AMLAnterior Mitral Leaflet
AMLACPI Machine Language
AMLAdjustable Mortgage Loan
AMLApplied Microsystems Ltd. (Canada)
AMLApproximate Maximum Likelihood (estimator)
AMLA Manufacturing Language (robotics programming language)
AMLApproved Manufacturer List
AMLAeronautical Materials Laboratory (US Navy)
AMLAdvanced Materials Laboratory
AMLAstronomical Markup Language
AMLAcquisition Master List (US Air Force)
AMLAircraft Maintenance License
AMLAriba Markup Language
AMLApplied Mathematics Laboratory
AMLArea Medical Laboratory
AMLAdaptive Modeling Language
AMLAmerican Medical Laboratories, Inc.
AMLAdministrative Message designated to Law Enforcement (Kansas)
AMLArchive for Mathematical Logic
AMLApproved Materials List
AMLAston Martin Lagonda Limited
AMLAmrad Corporation Limited
AMLAdditional Military Layer(s)
AMLAll My Loving (Beatles song)
AMLActual Measured Loss
AMLAmerican Mensa, Limited
AMLAsk Me Later
AMLAcronym Master List (Los Alamos National Laboratory)
AMLAssociation des Maires du Loiret (French: Association of Mayors of Loiret; Loiret, France)
AMLASN.1 Markup Language
AMLAcademia Medicinae Latviensis (Latvia)
AMLAutomated Mixed-media Library
AMLAnterior MidLine (front part of the body divided by an imaginary line through its center)
AMLArmy Medical Laboratory
AMLAirfield Marking and Lighting
AMLAlteration Material List (US Navy Ship Alteration Record Term)
AMLAmplitude-modulated Microwave Link
AMLAurora Macro Language
AMLAteliers Mécaniques de Lambersart (French: Lambersart Mechanical Workshops; Lambersart, France)
AMLAdaptive Maneuvering Logic
AMLAlliance pour une Médecine Libérale
AMLAdmiralty Materials Lab (UK)
AMLAmplitude Modulation with Noise Limiter
AMLAircraft Technical Manual List (TMINS)
AMLAlletess Medical Laboratory (Rockland, Massachusetts)
AMLAlternate Materials List
AMLAddition Modulo Length (coding scheme)
References in periodicals archive ?
Nucleophosmin gene mutations are predictors of favorable prognosis in acute myelogenous leukemia with a normal karyotype.
Acute myelogenous leukemia (AML) is a malignant disease of myeloid stem cells linked to oncogenic fusion proteins, which is due to chromosome translocations and inversions.
A section on hematological malignancies details management of infections in patients with different types of malignancies: acute myelogenous leukemia and febrile neutropenia, lymphomas and chronic lymphocytic leukemia, multiple myeloma, and stem cell transplantation.
Any breastfeeding for 6 months is associated with a 36% reduction in the risk of sudden infant death syndrome, a 19% reduction in the risk of childhood acute lymphocytic leukemia and related deaths, and a 15% reduction in the risk of acute myelogenous leukemia and related deaths.
Childhood leukemias, including acute lymphoblastic leukemia (ALL) and acute myelogenous leukemia (AML), are rare but potentially fatal cancers associated with substantial morbidity.
8 December 2009 - Stockholm-listed biopharmaceutical company Oxigene Inc (STO: OXGN) said today that its drug candidate OXi4503 for treatment of acute myelogenous leukemia (AML) has showed positive preclinical results.
Therapy-related acute myelogenous leukemia and myelodysplastic syndrome in patients with acute lymphoblastic leukemia treated with the hyperfractionated Cyclophosphamide, Vincristine, Doxorabicin, and Dexamethasone regimens.
Acute myelogenous leukemia (AML) develops as a consequence of a series of genetic changes in the hematopoietic precursor cells.
There are four major types of leukemia: acute myelogenous leukemia (AML), acute lymphocytic leukemia (ALL), chronic myelogenous leukemia (CML), and chronic lymphocytic leukemia (CLL).
Most patients develop bone marrow failure and need a bone marrow transplant, and many patients develop acute myelogenous leukemia (AML).
Full browser ?